"Tunnel" Flap vs Trapezoidal Flap for Lateral Sinus Lift

Sponsor
Studio Dentistico Associato Sivolella (Other)
Overall Status
Recruiting
CT.gov ID
NCT06105489
Collaborator
(none)
36
1
2
48
0.8

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to evaluate the efficacy of the lateral sinus lift procedure using the tunnel technique flap in comparison to the traditional lateral sinus lift in partially or totally edentulous patients with loss of teeth in the maxillary premolar or molar areas and severe alveolar atrophy. The primary questions it aims to answer are:

  1. Is the tunnel flap technique more suitable for lateral sinus lift than the trapezoidal flap technique in terms of post-operative symptoms?

  2. Is the tunnel technique safer and more effective than the trapezoidal flap technique in terms of complication rate and the effectiveness of bone grafting?

Participants will undergo the lateral sinus lift procedure using the tunnel technique, which involves making a vertical anterior incision. Patients will receive follow-up care, including phone contact the day after the procedure to detect any issues, and they will keep a diary during the week after surgery to record visual analog scale (VAS) pain values and analgesics taken. Follow-up surgical visits will be scheduled for suture removal and at 30 days after suture removal. After 6 months, dental implants will be inserted, and prosthetic rehabilitation will take place 6 months later. Implants will be monitored for up to 12 months after prosthetic rehabilitation.

Researchers will compare the outcomes of tunnel flap technique lateral sinus lift with the trapezoidal flap sinus lift.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Lateral Sinus Lift using tunnel flap technique
  • Procedure: Lateral Sinus Lift using crestal incision flap
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be assigned to one of two study arms, a test arm and a control arm, for the entire duration of the study.Participants will be assigned to one of two study arms, a test arm and a control arm, for the entire duration of the study.
Masking:
None (Open Label)
Masking Description:
Health care givers, investigators and outcome assessors cannot be masked to treatment allocation due to the characteristics of the intervention. The statistician will be masked to the treatment allocation during data analysis.
Primary Purpose:
Treatment
Official Title:
"Tunnel" Flap vs Trapezoidal Flap for Lateral Sinus Lift: A Prospective Randomized Study
Actual Study Start Date :
Oct 21, 2022
Anticipated Primary Completion Date :
Oct 21, 2024
Anticipated Study Completion Date :
Oct 21, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tunnel flap design

Participants will undergo a lateral sinus lift procedure in which a single vertical anterior incision will be made at least 10 mm mesially to the expected outline of the bony window.

Procedure: Lateral Sinus Lift using tunnel flap technique
The surgical procedure will involve the following steps: A single vertical anterior incision will be made, at least 10 mm mesially to the expected outline of the bony window. A full-thickness flap will be carefully elevated to expose the lateral wall of the maxillary sinus. A trap door will be created in the lateral wall of the maxillary sinus using either a dedicated piezosurgical insert or a straight handpiece with a 3mm round diamond bur. The door will be removed. The sinus membrane will be gently elevated using various-shaped curettes until it becomes completely detached from the lateral, inferior, and medial walls of the sinus. The maxillary sinus will be filled with a heterologous bone graft with a well-documented efficacy. The flaps will be meticulously sutured.

Active Comparator: Trapezioidal flap design

Participants will undergo a lateral sinus lift procedure. The incision will be made horizontally on the top of the alveolar ridge, with two additional releasing incisions in the mesial and distal regions.

Procedure: Lateral Sinus Lift using crestal incision flap
The surgical procedure will involve the following steps: A horizontal incision is made on the top of the alveolar ridge, along with two additional releasing incisions in the mesial and distal regions. A full-thickness flap will be carefully elevated to expose the lateral wall of the maxillary sinus. A trap door will be created in the lateral wall of the maxillary sinus using either a dedicated piezosurgical insert or a straight handpiece with a 3mm round diamond bur. The door will be removed. The sinus membrane will be gently elevated using various-shaped curettes until it becomes completely detached from the lateral, inferior, and medial walls of the sinus. The maxillary sinus will be filled with a heterologous bone graft with a well-documented efficacy. The flaps will be meticulously sutured.

Outcome Measures

Primary Outcome Measures

  1. Pain and discomfort on VAS scale at the 4th postoperative day [First week after sinus lift procedure]

    Participants will record the subjective post-operative pain/discomfort on a daily VAS score (0 to 10) for the first 7 days, at the same time each day, on a specific form. The VAS is a horizontal ruler 10 cm long with the left end (0 cm) indicating "no pain/discomfort at all" and the right limit (10 cm) indicating "the worst pain imaginable. Patients will be also asked to record the need for analgesics (including type and quantity).

Secondary Outcome Measures

  1. Times for surgical procedure [During sinus lift procedure]

    Surgical intervention duration (minutes) recorded from incision to the last suture (T1). Times for sinus mucosa elevation (T2) and for sinus filling (T3) will be measured as well.

  2. Soft tissue healing after sinus lift [10 days and 40 days after sinus lift procedure]

    Soft tissue healing will be evaluated using the scoring reported by Lin SL et al., at two timepoints: at suture removal and at 30 days after suture removal control. Assessments of wound healing will include 6 scoring categories, namely erythema, exudate, epithelialization, mucosa color, wound contour, and distortion of mucosa. Each category is scored on a 3-point scale (0, 1, or 2) and a total score from 0 to 3 represents good healing, a score from 4 to 6 represents satisfactory healing, a score from 7 to 9 represents disturbance of healing, and a score from 10 to 12 represents poor healing

  3. Sinus lift related complications [During sinus lift procedure, 1, 10 and 40 days from procedure.]

    Possible complications will be evaluated at various timepoints. During the surgical procedure through direct observation (bleeding, sinus membrane perforation, infraorbital nerve injury, perforation of the flap). The day after surgery through a telephone call to the patient (bleeding, flap dehiscence, hematoma, pain). At suture removal control after 10 +/- days after surgery (pain, infections, sinusitis, bone graft displacement, neuropathy, wound dehiscence). At 30 days after suture removal control (pain, infections, sinusitis, bone graft displacement, neuropathy).

  4. Graft healing after a 6 months period [6 months after implant procedure]

    A CBCT of the grafted area finalized to implants insertion planning will be taken after 6 months from the sinus lift. The parameters evaluated will be the final alveolar bone graft height calculated in correspondence of a line passing through the centre of the previous bone window; the presence of the contact between the bone graft and the medial or nasal wall of the sinus cavity; the regular distribution of the graft, intended as the presence of voids or displacements. Moreover a biopsy will be taken during implants insertion by means of a trefine.

Other Outcome Measures

  1. Bone quality [During implant insertion]

    Bone quality will be evaluated by means of Lekholm Zarb classification, ranging from D1 for dense cortical bone and D4 for fine trabecular bone.

  2. ISQ and RFA [During implant insertion, 12 months after sinus lift (prosthetic loading), 24 months after sinus lift]

    ISQ, ranging from 1 to 100, will be evaluated measuring RFA on two axis (palatal-buccal and mesial-distal) and their mean value will be collected.

  3. Insertion torque [During implant insertion]

    Maximum insertion torque will be collected

  4. Peri-implant marginal bone [During implant insertion, 12 months after sinus lift (prosthetic loading), 24 months after sinus lift]

    Peri-implant marginal bone variations (mm) will be measured on Periapical radiograph with a standardized technique will be obtained, using methods already described Marginal bone stability (eg Mameno, Tomoaki, et al. "Risk indicators for marginal bone resorption around implants in function for at least 4 years: A retrospective longitudinal study."Journal of periodontology 91.1 (2020): 37-45.)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • edentulous or partly edentulous patients with a unilateral loss of teeth in the maxillary premolar or molar areas

  • severe alveolar atrophy and a residual severe alveolar ridge height up to 3 mm

Exclusion Criteria:
  • severe illness

  • head and neck radiation therapy

  • chemotherapy

  • antiresorptive therapy

  • uncontrolled diabetes

  • uncontrolled periodontal disease

  • smoking >10 cigarettes per day

  • facial or neck inflammatory or oncologic diseases

  • obliteration of sinus ostium and osteomeatal complex

Contacts and Locations

Locations

Site City State Country Postal Code
1 Studio Dentistico Associato Graiff e Sivolella Padova Italy 35127

Sponsors and Collaborators

  • Studio Dentistico Associato Sivolella

Investigators

  • Principal Investigator: Stefano Sivolella, DDS, PhD, Studio Dentistico Associato Sivolella

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Studio Dentistico Associato Sivolella
ClinicalTrials.gov Identifier:
NCT06105489
Other Study ID Numbers:
  • 20464
First Posted:
Oct 27, 2023
Last Update Posted:
Oct 27, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Studio Dentistico Associato Sivolella
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 27, 2023